首页> 外国专利> PHENYL-3-{(3-(1H-PYRROL-2-YL)-1, 2 , 40XADIAZ0L-5-YLPIPERIDIN- 1-YL}-METHANONE DERIVATIVES AND RELATED COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS.

PHENYL-3-{(3-(1H-PYRROL-2-YL)-1, 2 , 40XADIAZ0L-5-YLPIPERIDIN- 1-YL}-METHANONE DERIVATIVES AND RELATED COMPOUNDS AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS.

机译:苯甲基-3-{(3-(1H-吡咯-2-基)-[1,2,4] 0XADIAZ0L-5-基]哌啶-1-基}-甲酮衍生物及相关化合物作为异戊二酸谷氨酸酯的正变位调节剂接收器。

摘要

The present invention provides new compounds of formula (I) as positive allosteric modulators of metabotropic receptors - subtype 5 ("mGluR5") which are useful for the treatment or prevention of central nervous system disorders such as for example, cognitive decline, both positive and negative symptoms in schizophrenia as well as other central or peripheral nervous system disorders in which the mGluR5 subtype of glutamate metabotropic receptor is involved. The invention is also directed to pharmaceutical compounds and compositions in the prevention or treatment of such diseases in which mGluR5 is involved. W represents (Csub4/sub-Csub7/sub)cycloalkyl, (Csub3/sub-Csub7/sub)heterocycloalkyl , (Csub3/sub-Csub7/sub)heterocycloalkyl-(Csub1/sub-C sub3/sub)alkyl or (Csub3/sub-Csub7/sub)heterocycloalkenyl ring; P represents a (Csub5/sub-Csub7/sub)heteroeycloalkyl, (Csub5/sub-Csub7/sub)heterocycloalkenyl ring or a heteroaryl group of formula (a), (b), (c), (d), (e), (f), (g), (h), (i). Q denotes a cycloalkyl, an aryl or heteroaryl group of formula (j), (k), (l), (m), (n). A is azo -N=N-, ethyl, ethenyl, ethynyl, -NRsub8/subC(=O)-, -NRsub8/subC(=O)-O-, -NRsub8/subC(=O)-NRsub9/sub, NRsub8/subS(=O)sub2/sub-, -C(=O)NRsub8/sub-, -O-C(=O)NRsub8/sub-, -S-, -S(=O)-, -S(=O)sub2/sub-, -S(C=O)sub2/subNRsub8/sub-, -C(=O)-O-, -O-C(=O)-, -C(=NRsub8/sub)NRsub9/sub-, C(C=NORsub8/sub)NRsub9/sub- , -NRsub8/subC(=NORsub9/sub)-, =N-O-, -O-N=CH- or a group aryl or heteroaryl of formula, (o), (p), (q), (r), (s), (t), (u), (v), (w), (x). The other substituents are defined in the claims.
机译:本发明提供式(I)的新化合物,作为代谢型受体的阳性变构调节剂-亚型5(“ mGluR5”),其可用于治疗或预防中枢神经系统疾病,例如阳性和阴性认知下降。精神分裂症以及其他涉及谷氨酸代谢型受体的mGluR5亚型的中枢或周围神经系统疾病的阴性症状。本发明还涉及预防或治疗涉及mGluR5的此类疾病的药物化合物和组合物。 W代表(C 4 -C 7 )环烷基,(C 3 -C 7 )杂环烷基,(C 3 -C 7 )杂环烷基-(C 1 -C 3 )烷基或(C 3 -C 7 )杂环烯基环; P代表(C 5 -C 7 )杂环烷基,(C 5 -C 7 )杂环烯基环或式(a),(b),(c),(d),(e),(f),(g),(h),(i)的杂芳基。 Q表示式(j),(k),(l),(m),(n)的环烷基,芳基或杂芳基。 A为偶氮-N = N-,乙基,乙烯基,乙炔基,-NR 8 C(= O)-,-NR 8 C(= O)-O- ,-NR 8 C(= O)-NR 9 ,NR 8 S(= O) 2 - ,-C(= O)NR 8 -,-OC(= O)NR 8 -,-S-,-S(= O)-,-S( = O) 2 -,-S(C = O) 2 NR 8 -,-C(= O)-O-,- OC(= O)-,-C(= NR 8 )NR 9 -,C(C = NOR 8 )NR 9 -,-NR 8 C(= NOR 9 )-,= NO-,-ON = CH-或下式的基团芳基或杂芳基, (o),(p),(q),(r),(s),(t),(u),(v),(w),(x)。其他取代基在权利要求中定义。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号